GEP Neuroendocrine Tumor
1 clinical trials · Condition
◉ Watch GEP Neuroendocrine Tumor
| Record | Firm | Date |
|---|---|---|
| A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) (NCT04893785) | National Cancer Institute, Naples | 2021-06-15 |
Track GEP Neuroendocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.